Can you provide the average price target for Q A D Inc Cl B stock?
7 analysts have analysed QADB and the average price target is 82.75 null. This implies a price decrease of -5.47% is expected in the next year compared to the current price of 87.54.
NASDAQ:QADB
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for Q A D Inc Cl B (QADB).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2021-06-28 | William Blair | Downgrade | Outperform -> Market Perform |
| 2021-04-08 | Sidoti & Co. | Downgrade | Buy -> Neutral |
| 2021-03-25 | Sidoti & Co. | Upgrade | Neutral -> Buy |
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | ||
|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 333M 9.18% | 310.8M -6.67% | 307.9M -0.93% | 343.762M 11.65% | 374.063M 8.81% | 403.408M 7.84% | 443.756M 10.00% | |
| EBITDA YoY % growth | 15.12M 466.29% | 710K -95.30% | 19.53M 2,650.70% | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | 9.6M 409.68% | -5.7M -159.38% | 12.7M 322.81% | N/A | N/A | N/A | N/A | |
| Operating Margin | 2.88% | -1.83% | 4.12% | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | 0.99 661.54% | 0.27 -72.73% | 1.25 362.96% | 1.38 10.43% | 1.47 6.40% | 1.91 30.21% | 2.54 32.81% |
| Q3 / 22 | Q4 / 22 | Q1 / 23 | |
|---|---|---|---|
| EPS Q2Q % growth | 0.37 8.00% | 0.38 -35.46% | 0.41 52.37% |
| Revenue Q2Q % growth | 91.345M 19.16% | 92.652M 11.66% | 98.213M 18.37% |
| EBITDA Q2Q % growth | N/A | N/A | N/A |
| EBIT Q2Q % growth | N/A | N/A | N/A |
7 analysts have analysed QADB and the average price target is 82.75 null. This implies a price decrease of -5.47% is expected in the next year compared to the current price of 87.54.
Q A D Inc Cl B (QADB) will report earnings on 2022-01-14.
The consensus EPS estimate for the next earnings of Q A D Inc Cl B (QADB) is 0.37 null and the consensus revenue estimate is 91.34M null.
The consensus rating for Q A D Inc Cl B (QADB) is 45.7143 / 100 . This indicates that analysts generally have a neutral outlook on the stock.